Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and year ended December 31, 2025.

Pfizer agreement announced in January 2026 for non-exclusive license to utilize Matrix-M® in two infectious disease areas Multiple Material Transfer Agreements signed ...

Q4 2025 Earnings Call February 26, 2026 8:30 AM ESTCompany ParticipantsLuis Sanay - Vice President of Investor RelationsJohn Jacobs ...

Inflammation comprises the detection and response to injury and pathogens, the accumulation and intervention of cells that eliminate invading microorganisms and infected host cells, and the repair of ...

Researchers from the University of Maryland, Lawrence Livermore, Columbia and TogetherAI have developed a training technique that triples LLM inference speed without auxiliary models or infrastructure ...

The resulting outcome is that you have A.I. systems that have learned what it means to solve a problem that takes quite a ...

Discover the top 4 undervalued Construction & Engineering stocks for Wednesday, February 25 based on AAII’s Stock Grades.

Lactalis debuts a ready‑to‑drink milk fortified with native type II collagen, targeting joint health, mobility and the rising ...

NHL action ignites after the Olympics. Exploit fatigue, injuries, and trades for late-season fantasy hockey wins. Maximize ...

The trial-to-trial variability of neuronal responses and the correlated response variability among neurons are modulated by visual stimulus size in a manner that depends on cortical layer, suggesting ...

A global team of scientists has identified an often-overlooked biological system — biofilms — as a critical factor in the future of human space ...